AN11--Multi-Omics Sequencing Services (Research Study Support)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Regional Procurement Office (RPO) - East, intends to award a sole source contract to NOVOGENE CORPORATION INC for multi-omics sequencing and analysis services. This contract will support a VA-funded research study at the VA Pittsburgh Healthcare System focused on identifying diagnostic biomarkers for Degenerative Cervical Myelopathy (DCM). This is a pre-solicitation notice, and no solicitation will be posted. Interested parties may contact the Contracting Officer by June 5, 2026.
Scope of Work
The study is a multi-omics project with specific constraints, including small pilot funding (less than $50K), a short timeframe (must be used by September 30, 2026), and the clinical research lab's lack of necessary equipment and expertise for high-order molecular biology, biochemistry, and bioinformatics. The project requires high-throughput processing of 120 blood samples (from 40 patients at multiple time points) to ensure comparability.
Specific tasks and deliverables include:
- Extracting metabolites from human plasma, performing omics analysis, and providing raw/analyzed data plus leftover samples.
- Extracting proteins from human plasma, performing O-link mass spectrometry and analysis, and providing raw/analyzed data plus leftover samples.
- Isolating RNA from human whole blood, performing poly-A enrichment and QC, constructing libraries, processing RNA samples, performing sequencing, and providing raw/analyzed data plus leftover samples.
Contract & Timeline
- Contract Type: Sole Source (Pre-Solicitation Notice)
- Duration: One (1) year
- Set-Aside: Not Applicable (Sole Source)
- NAICS Code: 541714 (Research and Development in Biotechnology), 1000 employee size standard
- PSC Code: AN11 (Health R&D Services; Health Care Services; Basic Research)
- Authority: FAR 6.302.1-1 (Only One Responsible Source)
- Response Date for Interested Parties: June 5, 2026, 15:59 UTC (11:59 AM Eastern Time)
- Published Date: May 29, 2026
Justification for Sole Source
Novogene Corporation Inc. is identified as the sole source due to its unique ability to provide a complete multi-omics pipeline, including sample preparation from human blood and comprehensive data analysis. This capability is crucial for managing technical variability, meeting the project's tight timeline and budget, and performing specialized discovery-based services like O-link proteomics and shotgun metabolomics, which are not widely offered by other companies. The VA determined that no other company could meet the study's requirements without reducing scope or compromising data quality.
Additional Notes
This is not a solicitation. Interested persons who believe they can meet the requirements may contact Ms. Millicent Covert, Contracting Officer, via email at millicent.covert@va.gov. The determination to conduct a competitive procurement based on responses is solely at the Contracting Officer's discretion.